Showing results (781-790 of 828) with videos related to

Sort By:
Pageof 83
Cancer Research|February 28, 2013
HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumabSuthinee Ithimakin, Kathleen C Day, Fayaz Malik, et al.
Epidemiology and Psychiatric Sciences|March 3, 2024
Incidence of mental health diagnoses during the COVID-19 pandemic: a multinational network studyYi Chai, Kenneth K C Man, Hao Luo, et al.
Molecular Endocrinology (Baltimore, Md.)|December 17, 2011
A SNP in steroid receptor coactivator-1 disrupts a GSK3β phosphorylation site and is associated with altered tamoxifen response in boneR J Hartmaier, A S Richter, R M Gillihan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2019
Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c TrialPriyanka Sharma, William E Barlow, Andrew K Godwin, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 7, 2018
Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definitionDiego Hidalgo-Mazzei, Michael Berk, Andrea Cipriani, et al.
Archives of Pathology & Laboratory Medicine|June 25, 2009
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancerAntonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, et al.
The Lancet. Psychiatry|May 4, 2023
Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 omicron infection and related hospital admission among people with substance use disorder in Hong Kong: a matched case-control studyCaige Huang, Yue Wei, Vincent K C Yan, et al.
Nature Genetics|November 5, 2013
Activating ESR1 mutations in hormone-resistant metastatic breast cancerDan R Robinson, Yi-Mi Wu, Pankaj Vats, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancerAntonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, et al.
Journal of the National Cancer Institute|November 7, 2019
Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307Julie R Gralow, William E Barlow, Alexander H G Paterson, et al.
Pageof 83